- 24 h
- 7 Tage
- 14 Tage
- 6 Monate
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Fendx Technologies Inc (2): Fendx shifts to liquid coating, works on catheter tech | 1 | Stockwatch | ||
| Di | SOLESENCE, INC. - 10-K, Annual Report | - | SEC Filings | ||
| Di | Solesence targets 30% gross margin floor in 2026 as it aims for 5% gross margin lift under Transform and Transcend | 1 | Seeking Alpha | ||
| Di | Solesence Flat on Q4 Numbers | - | Baystreet.ca | ||
| Di | Solesence GAAP EPS of $0.00, revenue of $12.5M | 1 | Seeking Alpha | ||
| Di | GomSpace A/S: GomSpace Secures 815.000 EUR (8.8 MSEK) Authorization to Proceed from Unseenlabs for Next Constellation Tranche | 247 | PR Newswire | STOCKHOLM, March 31, 2026 /PRNewswire/ -- GomSpace has received an Authorization to Proceed (ATP) valued at 815.000 EUR (8.8 MSEK) from Unseenlabs, a leading European provider of maritime... ► Artikel lesen | |
| Di | Solésence, Inc.: Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results | 167 | GlobeNewswire (Europe) | Full Year 2025 record revenue of $62.1 million ROMEOVILLE, Ill., March 31, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty... ► Artikel lesen | |
| Di | GOMSPACE GROUP AB: GomSpace Secures 815.000 EUR (8.8 MSEK) Authorization to Proceed from Unseenlabs for Next Constellation Tranche | 3 | Cision News | ||
| Di | BIOFORCE NANOSCIENCES HOLDINGS, INC. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | - | SEC Filings | ||
| Di | SOLESENCE, INC. - 8-K, Current Report | - | SEC Filings | ||
| Di | FendX Technologies Inc.: FendX Provides Corporate Update | 146 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - March 31, 2026) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), an innovative surface protection company... ► Artikel lesen | |
| Di | Nexsen Awarded $1.2m Grant to Advance Strepsure Point-Of-Care Diagnostic in Asia-Pacific Markets | 1 | smallcaps.com.au | ||
| Di | NANOPAC INNOVATION LIMITED: Annual Report 2025 (Price Sensitive) | - | ASX | ||
| Mo | NEXSEN LIMITED: HK$6 million grant awarded to advance Asia-Pacific execution | - | ASX | ||
| Mo | Craig-Hallum bestätigt Kopin-Aktie: Wachstum im Verteidigungssektor als Treiber | 3 | Investing.com Deutsch | ||
| Mo | Craig-Hallum reiterates Kopin stock rating on defense growth outlook | 2 | Investing.com | ||
| Mo | GomSpace A/S: GomSpace Draws EUR 7 Million Under Shareholder Credit Facility to Support Strategy Execution | 386 | PR Newswire | STOCKHOLM, March 30, 2026 /PRNewswire/ -- GomSpace announces the drawdown of EUR 7 million (SEK ~75 million) under the third tranche ("Tranche C") of the EUR 18 million shareholder credit... ► Artikel lesen | |
| Mo | GOMSPACE GROUP AB: GomSpace Draws EUR 7 Million Under Shareholder Credit Facility to Support Strategy Execution | 5 | Cision News | ||
| Mo | DOTZ NANO LIMITED: Results of Meeting | - | ASX | ||
| So | REGION GROUP: Update - Notification of buy-back - RGN | - | ASX |
1 2 Weiter >>
- 24 h
- 7 Tage
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | Aktuelle Nachrichten | |||
|---|---|---|---|---|---|---|---|
| SOLESENCE | 6 | 2 | -0,97 % | Solésence, Inc.: Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results | Full Year 2025 record revenue of $62.1 million ROMEOVILLE, Ill., March 31, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty... ► Artikel lesen | ||
| FENDX TECHNOLOGIES | 2 | 2 | +3,88 % | FendX Technologies Inc.: FendX Provides Corporate Update | Vancouver, British Columbia--(Newsfile Corp. - March 31, 2026) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), an innovative surface protection company... ► Artikel lesen | ||
| GOMSPACE | 2 | 1 | +0,59 % | GomSpace A/S: GomSpace Secures 815.000 EUR (8.8 MSEK) Authorization to Proceed from Unseenlabs for Next Constellation Tranche | STOCKHOLM, March 31, 2026 /PRNewswire/ -- GomSpace has received an Authorization to Proceed (ATP) valued at 815.000 EUR (8.8 MSEK) from Unseenlabs, a leading European provider of maritime... ► Artikel lesen | ||
| BIOFORCE NANOSCIENCES | 1 | - | - | BIOFORCE NANOSCIENCES HOLDINGS, INC. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | |||
| NEXSEN | 1 | - | - | Nexsen Awarded $1.2m Grant to Advance Strepsure Point-Of-Care Diagnostic in Asia-Pacific Markets | |||
| ONTO INNOVATION | - | 6 | -0,60 % | Onto Innovation stock holds at Stifel on HBM customer win | |||
| NANOFOCUS | - | 3 | +1,08 % | Nanofocus: Aus in München und Berlin | Im November hat eine außerordentliche Hauptversammlung von Nanofocus beschlossen, die Aktien der Minderheitsaktionäre auf die Carl Mahr Holding zu übertragen. Dies ist der Hauptaktionär der Oberhausener.... ► Artikel lesen | ||
| FORMYCON | - | 3 | 0,00 % | ANLEIHEN-Woche KW12 - 2026: Mutares, Finexity, Circus, Südzucker, Planethic Group, Formycon, PNE, Homann, PCC, Energiekontor, uvm. | Dialoge, Transaktionen und Kennzahlen In der Kalenderwoche 12 richtet sich der Blick am Anleihemarkt nicht nur auf konkrete Transaktionen, sondern auch auf den intensiven Dialog zwischen Emittenten... ► Artikel lesen | ||
| ANTEOTECH | - | 3 | - | ANTEOTECH LTD: Presentation to NWR Virtual Healthcare Conference | |||
| ZENTEK | - | 3 | +13,33 % | Zentek Ltd.: Triera Biosciences - a Zentek Company - Launches Contract Research Organization Services for Custom Aptamer Discovery, Biosensor Enablement, and Machine-Learning Classification | Backed by an Exclusive 20-Year McMaster University License, Triera Targets High-Priority Infectious Disease and Oncology Detection Markets Across Canada, the United States, and Europe GUELPH, ON / ACCESS... ► Artikel lesen |
- Alle
| Unternehmen / Aktien | Aktueller Kurs | Ø Kursziel (Euro) | Potential (Euro) | kaufen | halten | verkaufen | |||
|---|---|---|---|---|---|---|---|---|---|
| Es sind keine Aktien verfügbar, die den gewählten Kriterien entsprechen. | |||||||||
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.